Meta-analysis of Unguided Deescalation of Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

被引:0
|
作者
Mohamed, Mohamed M. G. [1 ]
Shaikh, Safia [1 ]
Osman, Mohammed [2 ]
Kheiri, Babikir [2 ]
机构
[1] SSM Hlth St Marys Hosp, Internal Med Dept, 6420 Clayton Rd,Suite 2218, St Louis, MO 63117 USA
[2] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR USA
关键词
ACUTE MYOCARDIAL-INFARCTION; DE-ESCALATION; CLOPIDOGREL;
D O I
10.1055/a-1827-8128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:e144 / e146
页数:3
相关论文
共 50 条
  • [31] Efficacy and Safety of Shortened Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Hui, Jiaojiao
    Bai, Ting
    Liang, Le
    He, Qingqing
    Tian, Nani
    Li, Xiao
    Yang, Rui
    Zhu, Lin
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 80 (05) : 700 - 708
  • [32] Short dual antiplatelet therapy in patients with high bleeding risk undergoing percutaneous coronary intervention: a systematic review and meta-analysis
    Zhang, Junyan
    Chen, Zhongxiu
    Li, Chen
    Wang, Duolao
    He, Siyu
    Luo, Chaoyu
    Luo, Fangbo
    He, Yong
    CORONARY ARTERY DISEASE, 2022, 33 (07) : 580 - 589
  • [33] Meta-Analysis of Duration of Dual Antiplatelet Therapy in Acute Coronary Syndrome Treated With Coronary Stenting
    Knijnik, Leonardo
    Fernandes, Marcelo
    Rivera, Manuel
    Cardoso, Rhanderson
    Goyal, Abhinav
    Liberman, Henry
    Sperling, Laurence S.
    McDaniel, Michael C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 151 : 25 - 29
  • [34] Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention
    Bagai, Akshay
    Bhatt, Deepak L.
    Eikelboom, John W.
    Mancini, G. B. John
    Cohen, Eric A.
    Vijayaraghavan, Ram
    Cheema, Asim N.
    Udell, Jacob A.
    Niznick, Joel
    Tanguay, Jean-Francois
    Verma, Subodh
    Mehta, Shamir R.
    CIRCULATION, 2016, 133 (21) : 2094 - 2098
  • [35] Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome
    Deharo, Pierre
    Cuisset, Thomas
    TRENDS IN CARDIOVASCULAR MEDICINE, 2020, 30 (04) : 198 - 202
  • [36] Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
    Han, Jialun
    Zhang, Yi
    Shi, Xiujin
    Lin, Baidi
    Zhang, Yunnan
    Zhang, Ru
    Wang, Yifan
    Yan, Jialin
    Lin, Yang
    GLOBAL HEART, 2023, 18 (01)
  • [37] Optimizing antiplatelet therapy in acute coronary syndrome and percutaneous coronary intervention
    Faxon, David P.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 79 (02) : 181 - 197
  • [38] Safety and Efficacy of Ticagrelor versus Clopidogrel in East Asian Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Treated with Dual Antiplatelet Therapy: A Meta-Analysis of Randomized Controlled Trials
    Li, Jingyuan
    Wang, Qian
    Wu, Chunliu
    Qu, Xiaoyu
    Zhang, Lei
    He, Xiaofeng
    Ma, Sicong
    Qiu, Miaohan
    Wang, Xiaozeng
    CARDIOLOGY, 2023, 148 (04) : 363 - 373
  • [39] Genotype-guided antiplatelet therapy compared with standard therapy for patients with acute coronary syndromes or undergoing percutaneous coronary intervention: A systematic review and meta-analysis
    Wang, Xin
    Wang, Shihui
    Yang, Jing
    Yu, Xiaojia
    Liu, Lihong
    THROMBOSIS RESEARCH, 2020, 193 : 130 - 138
  • [40] UNGUIDED VERSUS GUIDED ALTERATION OF DUAL ANTIPLATELET THERAPY AFTER ACUTE CORONARY SYNDROME: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Fujisaki, Tomohiro
    Kuno, Toshiki
    Shoji, Satoshi
    Sahashi, Yuki
    Takagi, Hisato
    Briasoulis, Alexandros
    Deharo, Pierre
    Cuisset, Thomas
    Latib, Azeem
    Kohsaka, Shun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1024 - 1024